EcoR1 Capital as of Dec. 31, 2020
Portfolio Holdings for EcoR1 Capital
EcoR1 Capital holds 66 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Xencor (XNCR) | 10.7 | $198M | 4.5M | 43.63 | |
| Relay Therapeutics (RLAY) | 7.2 | $133M | 3.2M | 41.56 | |
| Shattuck Labs (STTK) | 6.9 | $129M | 2.5M | 52.41 | |
| Silverback Therapeutics (SPRY) | 6.3 | $117M | 2.5M | 46.34 | |
| Prothena Corp SHS (PRTA) | 6.1 | $113M | 9.4M | 12.01 | |
| Oric Pharmaceuticals (ORIC) | 5.6 | $105M | 3.1M | 33.85 | |
| Mirati Therapeutics | 5.5 | $102M | 464k | 219.64 | |
| Morphic Hldg (MORF) | 5.1 | $95M | 2.8M | 33.55 | |
| Anaptysbio Inc Common (ANAB) | 3.7 | $69M | 3.2M | 21.50 | |
| Biogen Idec Call Option (BIIB) | 3.3 | $62M | 254k | 244.86 | |
| Solid Biosciences | 3.3 | $61M | 8.0M | 7.58 | |
| Kura Oncology (KURA) | 3.1 | $58M | 1.8M | 32.66 | |
| Arcus Biosciences Incorporated (RCUS) | 3.1 | $57M | 2.2M | 25.96 | |
| Avidity Biosciences Ord (RNA) | 2.9 | $54M | 2.1M | 25.52 | |
| Nurix Therapeutics (NRIX) | 2.7 | $51M | 1.5M | 32.88 | |
| Neoleukin Therapeutics | 2.4 | $44M | 3.1M | 14.10 | |
| Atreca Cl A Com (BCEL) | 2.1 | $39M | 2.4M | 16.15 | |
| Akouos | 2.1 | $39M | 2.0M | 19.83 | |
| Applied Molecular Trans | 1.9 | $35M | 1.2M | 30.77 | |
| Geron Corporation (GERN) | 1.6 | $30M | 19M | 1.59 | |
| Gossamer Bio Note (Principal) | 1.5 | $27M | 30M | 0.91 | |
| Chinook Therapeutics | 1.1 | $20M | 1.3M | 15.86 | |
| Allovir (ALVR) | 0.9 | $17M | 447k | 38.44 | |
| Gritstone Oncology Ord (GRTSQ) | 0.7 | $14M | 3.4M | 3.94 | |
| Ac Immune Sa SHS (ACIU) | 0.7 | $13M | 2.4M | 5.17 | |
| Kronos Bio | 0.6 | $12M | 387k | 29.87 | |
| Syros Pharmaceuticals | 0.6 | $11M | 1.0M | 10.85 | |
| Vincera Pharma | 0.5 | $10M | 481k | 20.91 | |
| Aclaris Therapeutics (ACRS) | 0.5 | $9.8M | 1.5M | 6.47 | |
| Alpine Immune Sciences | 0.5 | $9.3M | 741k | 12.60 | |
| Bctg Acquisition Corp | 0.5 | $9.2M | 800k | 11.44 | |
| Iteos Therapeutics | 0.5 | $8.8M | 260k | 33.82 | |
| Deerfield Healthcare Techn A | 0.4 | $7.5M | 482k | 15.60 | |
| Cerevel Therapeutics Hldng I (CERE) | 0.4 | $6.6M | 400k | 16.58 | |
| C4 Therapeutics (CCCC) | 0.4 | $6.6M | 200k | 33.13 | |
| Kymera Therapeutics (KYMR) | 0.3 | $6.2M | 100k | 62.00 | |
| Logicbio Therapeutics | 0.3 | $5.9M | 775k | 7.63 | |
| Jiya Acquisition Corp | 0.3 | $5.2M | 500k | 10.30 | |
| Health Sciences Acq Corp 2 Ord SHS | 0.3 | $5.1M | 400k | 12.81 | |
| Panacea Acquisition Corp Unit 99/99/9999 | 0.3 | $5.0M | 390k | 12.76 | |
| Cyclerion Therapeutics | 0.3 | $4.9M | 1.6M | 3.06 | |
| Galapagos Nv Spon Adr (GLPG) | 0.2 | $4.6M | 47k | 98.98 | |
| Dyne Therapeutics (DYN) | 0.2 | $4.5M | 215k | 21.00 | |
| Ngm Biopharmaceuticals | 0.2 | $4.3M | 144k | 30.29 | |
| Codiak Biosciences | 0.2 | $3.7M | 115k | 32.30 | |
| Vincera Pharma *w Exp | 0.2 | $3.1M | 150k | 20.91 | |
| Pmv Pharmaceuticals (PMVP) | 0.2 | $3.1M | 50k | 61.52 | |
| Gossamer Bio (GOSS) | 0.2 | $2.8M | 294k | 9.67 | |
| Metacrine Ord | 0.1 | $2.6M | 333k | 7.86 | |
| Helix Acquisition Corp | 0.1 | $2.3M | 200k | 11.37 | |
| Bcls Acquisition Corp | 0.1 | $2.2M | 200k | 11.14 | |
| Lifesci Acquisition Ii Corp | 0.1 | $2.1M | 200k | 10.67 | |
| Eucrates Biomedical Acqu Cor Unit | 0.1 | $2.1M | 200k | 10.66 | |
| Consonance Hfw Acquisition C Unit | 0.1 | $2.1M | 200k | 10.47 | |
| Frazier Lifesciences Acqu Unit | 0.1 | $2.1M | 200k | 10.38 | |
| 5 01 Acquisition Corp Cl A | 0.1 | $2.0M | 200k | 10.17 | |
| Sutro Biopharma (STRO) | 0.1 | $2.0M | 93k | 21.71 | |
| Repare Therapeutics Ord (RPTX) | 0.1 | $1.7M | 50k | 34.30 | |
| Bioatla (BCAB) | 0.1 | $1.7M | 50k | 34.02 | |
| Deerfield Healthcare Tech Ac *w Exp | 0.1 | $1.6M | 100k | 15.60 | |
| Meiragtx Holdings (MGTX) | 0.1 | $1.4M | 95k | 15.14 | |
| Turmeric Acquisition Corp Unit | 0.1 | $1.0M | 100k | 10.27 | |
| Kinnate Biopharma | 0.1 | $995k | 25k | 39.80 | |
| Intercept Pharmaceuticals In Call Option | 0.0 | $625k | 25k | 24.70 | |
| Surface Oncology | 0.0 | $449k | 49k | 9.25 | |
| Assembly Biosciences Call Option | 0.0 | $108k | 18k | 6.07 |